Cargando…
Direct evidence on the efficacy of GnRH agonist in recurrent steroid cell tumor-not otherwise specified
BACKGROUND: Steroid cell tumor (SCT) not otherwise specified (NOS) is rare and recurrence and metastasis rarely occurs; therefore, reports regarding its treatment are limited. We report a case of recurrent SCT-NOS treated with gonadotropin releasing hormone agonist (GnRHa) and successful. CASE: A 50...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6660559/ https://www.ncbi.nlm.nih.gov/pubmed/31372485 http://dx.doi.org/10.1016/j.gore.2019.07.006 |